Congress Increases Funding for Alzheimer’s Disease and Other Dementia Research

House and Senate Committees on appropriations released their final bipartisan FY2026 Labor–Health and Human Services–Education appropriations bill.

UsAgainstAlzheimer’s Statement on Initial Findings from Novo Nordisk Alzheimer’s EVOKE and EVOKE+ Trials

UsAgainstAlzheimer’s released the following statement after Novo Nordisk announced results from its phase 3 EVOKE and EVOKE+ trials.

This November, we’re honoring Alzheimer’s Awareness Month.

Understand your brain health today — and take the first step with BrainGuide.

UsAgainstAlzheimer’s Applauds Senate Appropriators for Robust Investments in Alzheimer’s Programs

These significant investments in research underscore the millions of Americans impacted by Alzheimer’s and other dementias.

UsAgainstAlzheimer’s Launches Clinical Trial Connector to Improve Access to Alzheimer’s Research

UsAgainstAlzheimer's announced the launch of the BrainGuide Clinical Trial Connector, a free, confidential tool developed in partnership with Carebox. This new resource helps individuals, caregivers, and healthcare providers easily find and connect with clinical trials for Alzheimer’s disease and related dementias (ADRD).

Join the UsAgainstAlzheimer's Membership Program

Become a Member of UsAgainstAlzheimer's today and join a movement of people who don’t just talk about the Alzheimer’s crisis, but become part of the solution.

Congress Increases Research Funding

Statement on Initial Findings from Novo Nordisk Alzheimer’s EVOKE and EVOKE+ Trials

Early detection can change lives.

UsAgainstAlzheimer’s Applauds Robust Investments in Alzheimer’s Programs

UsAgainstAlzheimer’s Launches Clinical Trial Connector to Improve Access to Alzheimer’s Research

Become a Member

VISION: UsAgainstAlzheimer's envisions a world without Alzheimer's where brainspan equals lifespan. 

MISSION: Catalyze change in the health ecosystem to improve dementia prevention, early detection, and access to treatments through advocacy, policy, convening, and high-leveraged programs, with a particular focus on health equity.   

 

Prevention

Alzheimer’s is not a normal part of aging. There are things we can all do to reduce our risk, like eating a healthy diet, exercising, and getting good sleep. People need to know what’s good for the body is good for the brain. Learn more about our prevention work and how you can take charge of your brain health.

CLICK HERE FOR MORE INFO

Early Detection & Diagnosis

Early detection and diagnosis give people a better chance of managing the disease. On top of that, current treatments are most effective with patients in the early stages of dementia.

Find out how we are raising awareness of the importance of early detection and how BrainGuide is helping people concerned about their brain health start a conversation with their doctor.

CLICK HERE FOR MORE INFO

Access to Treatments

We are working on multiple fronts to get safe and effective treatments into the hands of people who need them most. That includes working to ensure Alzheimer’s patients are treated fairly as the federal government considers drug approval and Medicare coverage for treatments.

See how else UsAgainstAlzheimer’s is fighting for access to treatments.

CLICK HERE FOR MORE INFO

 

Center for Brain Health Equity

Most Alzheimer’s patients are women, Latinos, and Black people. As a patient-centered organization, all our work is done with equity in mind, so we are addressing needs of the people who are most heavily impacted by the disease. Learn more about how UsAgainstAlzheimer’s Center for Brain Health Equity is working toward a healthcare system that works for everyone.

Recent News and Blog Posts

  • January 27, 2025

    UsAgainstAlzheimer’s Applauds FDA Approval of Leqembi® Monthly Dosing

    UsAgainstAlzheimer’s chair and co-founder George Vradenburg issued the following statement in response...

    Read more
  • December 12, 2024

    BOLD Act Signed into Law to Strengthen Alzheimer’s Research and Support

    UsAgainstAlzheimer’s applauds the signing of the Building Our Largest Dementia (BOLD) Infrastructure...

    Read more
  • November 22, 2024

    Senate Passes BOLD Act to Strengthen Alzheimer's Public Health Response

    UsAgainstAlzheimer’s chair and co-founder, George Vradenburg, issued the following statement in response...

    Read more
  • November 14, 2024

    UsAgainstAlzheimer’s Statement on Alzheimer’s Treatment Approval in the European Union

    UsAgainstAlzheimer’s applauds the Committee for Medicinal Products for Human Use (CHMP) of...

    Read more
  • Centers for Medicare and Medicaid Services: Appropriately cover the costs of blood tests helping to detect Alzheimer’s

    UsAgainstAlzheimer’s, along with a coalition of leading advocacy groups, is calling for...

    Read more
  • October 23, 2024

    Members of Congress Call for More Action on Alzheimer’s

    Read more

Reports

  • Resources
    report

    2024 Annual Report

  • Resources
    2023 report

    2023 Annual Report

  • Resources

    2022 Annual Report